Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000153992 | SCV000203617 | likely benign | not specified | 2017-08-28 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001084839 | SCV000562998 | benign | Early infantile epileptic encephalopathy with suppression bursts | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics Inc | RCV000713511 | SCV000844132 | benign | not provided | 2018-04-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002316974 | SCV000850632 | likely benign | Inborn genetic diseases | 2019-02-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000713511 | SCV001753147 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001808422 | SCV002056666 | benign | Developmental and epileptic encephalopathy, 5 | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000713511 | SCV003917709 | likely benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | SPTAN1: BS1 |
Center for Genomics, |
RCV001808422 | SCV003920506 | likely benign | Developmental and epileptic encephalopathy, 5 | 2022-07-12 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature but is present in the Genome Aggregation Database (Highest reported MAF 0.2% (331/129180) including 1 homozygote (https://gnomad.broadinstitute.org/variant/9-131367308-T-G?dataset=gnomad_r2_1). This variant is present in ClinVar, with several labs classifying this variant as Likely Benign or Benign (Variation ID:167720). Evolutionary conservation and computational predictive tools for this variant are limited or unavailable. This variant is an intronic variant with no predicted change in the amino acid sequence but may have an unknown effect on splicing. Splice prediction tools suggest that this variant may affect splicing. However, further studies are needed to understand its impact. In summary, data on this variant suggests that this variant does not cause disease but requires further evidence. Therefore, this variant is classified as likely benign. |
Prevention |
RCV003975206 | SCV004793989 | likely benign | SPTAN1-related condition | 2024-01-05 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Bioinformatics Core, |
RCV000656024 | SCV000588300 | pathogenic | Childhood epilepsy with centrotemporal spikes | 2017-01-01 | flagged submission | case-control | CAADphred>15 |
Genome Diagnostics Laboratory, |
RCV000713511 | SCV001978171 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000713511 | SCV001980484 | likely benign | not provided | no assertion criteria provided | clinical testing |